Literature DB >> 8995627

Oncogenesis of mammary glands, skin, and bones by polyomavirus correlates with viral persistence and prolonged genome replication potential.

J J Wirth1, L G Martin, M M Fluck.   

Abstract

A correlation between polyomavirus-induced oncogenesis and viral persistence on the one hand and/or prolonged genome replication potential on the other was established with respect to their respective organ distributions. Prolonged replication potential is defined as the capacity of a genome to replicate in a given organ from the time of infection up to the onset of oncogenesis. This conclusion was derived following intraperitoneal infection of BALB/c mice with wild-type strain A2. Viral genomes were used as parameters of persistence and replication and were detected by Southern blotting and PCR analysis. The major tumor target organs (mammary gland, skin, and bone), which have not been previously analyzed for persistence, were compared with other, non-tumor-prone organs (kidney, liver, lung, spleen, and salivary gland). A progressive loss of viral genomes was observed in all tissues as a function of time postinfection; however, genomes were shown to persist through 20 weeks postinfection in the mammary glands, skin, and bones to an extent similar to that in the previously described kidneys (D. J. McCance, J. Virol. 39:958-962, 1981; W. P. Rowe, J. W. Hartley, J. D. Estes, and R. J. Huebner, Natl. Cancer Inst. Monogr. 4:189-209, 1960). Thus, tumors arise among organs that sustain a persistent infection, but not all such organs develop tumors (e.g., the kidney). The capacity of organs to support de novo replication at various ages, including the age reached when the first tumors are detected, was also determined using a 3-day infection period for ages between 0 and 7 weeks. For all organs tested, a higher level of genomes was observed in organs of mice infected as neonates than in those infected after the age of 3 weeks. However, marked organ-specific differences were seen in the degree and timing of loss of replication. In particular, viral genome replication, although reduced, was maintained in the mammary glands, skin, and bones of adult animals, in contrast to the kidneys. We conclude that organ-specific oncogenesis correlates with two organ-specific parameters: persistence of viral genomes and prolonged viral genome replication potential. This may reflect a requirement for continued viral genome replication and/or gene expression for tumorigenesis. In turn, these parameters may be linked to the tissue-specific continued capacity for cellular division.

Entities:  

Mesh:

Year:  1997        PMID: 8995627      PMCID: PMC191158     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  24 in total

1.  Growth curves of polyoma virus in mice and hamsters.

Authors:  W P ROWE; J W HARTLEY; J D ESTES; R J HUEBNER
Journal:  Natl Cancer Inst Monogr       Date:  1960-09

2.  Regulation of c-myc and c-fos mRNA levels by polyomavirus: distinct roles for the capsid protein VP1 and the viral early proteins.

Authors:  J Zullo; C D Stiles; R L Garcea
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

3.  Polyoma DNA: a physical map.

Authors:  B E Griffin; M Fried; A Cowie
Journal:  Proc Natl Acad Sci U S A       Date:  1974-05       Impact factor: 11.205

4.  Persistence of polyomavirus in mice infected as adults differs from that observed in mice infected as newborns.

Authors:  Z Berke; T Dalianis
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

5.  Reactivation of polyoma virus in kidneys of persistently infected mice during pregnancy.

Authors:  D J McCance; C A Mims
Journal:  Infect Immun       Date:  1979-09       Impact factor: 3.441

6.  The primary site of replication alters the eventual site of persistent infection by polyomavirus in mice.

Authors:  T W Dubensky; L P Villarreal
Journal:  J Virol       Date:  1984-05       Impact factor: 5.103

7.  Different roles for two enhancer domains in the organ- and age-specific pattern of polyomavirus replication in the mouse.

Authors:  A Amalfitano; L G Martin; M M Fluck
Journal:  Mol Cell Biol       Date:  1992-08       Impact factor: 4.272

8.  Specific tissue targeting of polyoma virus oncogenicity in athymic nude mice.

Authors:  M Berebbi; L Dandolo; J Hassoun; A M Bernard; D Blangy
Journal:  Oncogene       Date:  1988-02       Impact factor: 9.867

9.  Persistence of animal and human papovaviruses in renal and nervous tissues.

Authors:  D J McCance
Journal:  Prog Clin Biol Res       Date:  1983

10.  Variations in polyoma virus genotype in relation to tumor induction in mice. Characterization of wild type strains with widely differing tumor profiles.

Authors:  C J Dawe; R Freund; G Mandel; K Ballmer-Hofer; D A Talmage; T L Benjamin
Journal:  Am J Pathol       Date:  1987-05       Impact factor: 4.307

View more
  5 in total

1.  Expression of major capsid protein VP-1 in the absence of viral particles in thymomas induced by murine polyomavirus.

Authors:  N Sanjuan; A Porrás; J Otero; S Perazzo
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

2.  Systemic polyomavirus genome increase and dissemination of capsid-defective genomes in mammary gland tumor-bearing mice.

Authors:  J J Wirth; L Chen; M M Fluck
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

Review 3.  Pathogen-host standoff: immunity to polyomavirus infection and neoplasia.

Authors:  Aron E Lukacher
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

Review 4.  Immunity to polyomavirus infection: the polyomavirus-mouse model.

Authors:  Phillip A Swanson; Aron E Lukacher; Eva Szomolanyi-Tsuda
Journal:  Semin Cancer Biol       Date:  2009-02-14       Impact factor: 15.707

5.  Evaluation of the Gastrointestinal Tract as Potential Route of Primary Polyomavirus Infection in Mice.

Authors:  Gang Huang; Gang Zeng; Yuchen Huang; Bala Ramaswami; Parmjeet Randhawa
Journal:  PLoS One       Date:  2016-03-03       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.